Glyscend, Inc. — Form D
Glyscend, Inc. of BALTIMORE, MD, a company, filed a Form D exempt-offering notice with the SEC on 2020-02-21. The offering totals $20.9M, of which $4.8M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2020-02-21
- Form: D
- Accession: 0001804326-20-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $20.9M
- Amount sold: $4.8M
- Remaining: $16.1M
- Minimum investment: $1
- Investors: 10
- Date of first sale: 2020-02-07
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-361166
Issuer
- Name: Glyscend, Inc.
- CIK: 0001804326
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 1812 ASHLAND AVE #110, BALTIMORE, MD, 21205
- Phone: 443-961-2147
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Casey Cunningham | Director | Milwaukee, WI |
| Dennis McWilliams | Director | Austin, TX |
| Ashish Nimgaonkar | Director | Baltimore, MD |
| LEIGHTON READ | Director | Sunnyvale, CA |
| Bob Soh | Director | Baltimore, MD |
| Ashish Nimgaonkar | Executive Officer | Baltimore, MD |
More